Literature DB >> 25930990

The macrophage migration inhibitory factor protein superfamily in obesity and wound repair.

Bong-Sung Kim1, Norbert Pallua2, Jürgen Bernhagen3, Richard Bucala4.   

Abstract

The rising number of obese individuals has become a major burden to the healthcare systems worldwide. Obesity includes not only the increase of adipose tissue mass but importantly also the altered cellular functions that collectively lead to a chronic state of adipose tissue inflammation, insulin resistance and impaired wound healing. Adipose tissue undergoing chronic inflammation shows altered cytokine expression and an accumulation of adipose tissue macrophages (ATM). The macrophage migration inhibitory factor (MIF) superfamily consists of MIF and the recently identified homolog D-dopachrome tautomerase (D-DT or MIF-2). MIF and D-DT, which both bind to the CD74/CD44 receptor complex, are differentially expressed in adipose tissue and have distinct roles in adipogenesis. MIF positively correlates with obesity as well as insulin resistance and contributes to adipose tissue inflammation by modulating ATM functions. D-DT, however, is negatively correlated with obesity and reverses glucose intolerance. In this review, their respective roles in adipose tissue homeostasis, adipose tissue inflammation, insulin resistance and impaired wound healing will be reviewed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25930990      PMCID: PMC4454997          DOI: 10.1038/emm.2015.26

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  90 in total

1.  Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid-induced apoptosis.

Authors:  Tamara Saksida; Stanislava Stosic-Grujicic; Gordana Timotijevic; Stellan Sandler; Ivana Stojanovic
Journal:  Immunol Cell Biol       Date:  2011-11-08       Impact factor: 5.126

Review 2.  A decade of progress in adipose tissue macrophage biology.

Authors:  Andrea A Hill; W Reid Bolus; Alyssa H Hasty
Journal:  Immunol Rev       Date:  2014-11       Impact factor: 12.988

3.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

4.  Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.

Authors:  Stanislava Stosic-Grujicic; Ivana Stojanovic; Danijela Maksimovic-Ivanic; Miljana Momcilovic; Dusan Popadic; Ljubica Harhaji; Djordje Miljkovic; Christine Metz; Katia Mangano; Gianpaolo Papaccio; Yousef Al-Abed; Ferdinando Nicoletti
Journal:  J Cell Physiol       Date:  2008-06       Impact factor: 6.384

5.  Differences in mRNA expression of adipocyte-derived factors in response to fasting, refeeding and leptin.

Authors:  Fabrice Bertile; Thierry Raclot
Journal:  Biochim Biophys Acta       Date:  2004-07-05

6.  Circulating mononuclear cells in the obese are in a proinflammatory state.

Authors:  Husam Ghanim; Ahmad Aljada; Deborah Hofmeyer; Tufail Syed; Priya Mohanty; Paresh Dandona
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690

7.  UVB-induced inflammation gives increased d-dopachrome tautomerase activity in blister fluid which correlates with macrophage migration inhibitory factor.

Authors:  Björn Sonesson; Evald Rosengren; Ann-Sofie Hansson; Christer Hansson
Journal:  Exp Dermatol       Date:  2003-06       Impact factor: 3.960

8.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

Review 9.  Disclosure of the Culprits: Macrophages-Versatile Regulators of Wound Healing.

Authors:  Anca Sindrilaru; Karin Scharffetter-Kochanek
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-09       Impact factor: 4.730

10.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.

Authors:  T Calandra; J Bernhagen; R A Mitchell; R Bucala
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Joshua B Bilsborrow; Edward Doherty; Pathricia V Tilstam; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2019-08-20       Impact factor: 6.902

2.  Asperosaponin VI promotes angiogenesis and accelerates wound healing in rats via up-regulating HIF-1α/VEGF signaling.

Authors:  Cheng-Gui Wang; Yi-Ting Lou; Min-Ji Tong; Li-Lian Zhang; Zeng-Jie Zhang; Yong-Zeng Feng; Shi Li; Hua-Zi Xu; Cong Mao
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

Review 3.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

4.  Differential regulation of macrophage activation by the MIF cytokine superfamily members MIF and MIF-2 in adipose tissue during endotoxemia.

Authors:  Bong-Sung Kim; Pathricia V Tilstam; Kevin Arnke; Lin Leng; Tim Ruhl; Marta Piecychna; Wibke Schulte; Maor Sauler; Florian S Frueh; Gabriele Storti; Nicole Lindenblatt; Pietro Giovanoli; Norbert Pallua; Jürgen Bernhagen; Richard Bucala
Journal:  FASEB J       Date:  2020-01-21       Impact factor: 5.191

5.  Global epigenetic alterations of mesenchymal stem cells in obesity: the role of vitamin C reprogramming.

Authors:  Mohsen Afarideh; Roman Thaler; Farzaneh Khani; Hui Tang; Kyra L Jordan; Sabena M Conley; Ishran M Saadiq; Yasin Obeidat; Aditya S Pawar; Alfonso Eirin; Xiang-Yang Zhu; Amir Lerman; Andre J van Wijnen; Lilach O Lerman
Journal:  Epigenetics       Date:  2020-09-20       Impact factor: 4.528

6.  D-dopachrome tautomerase activates COX2/PGE2 pathway of astrocytes to mediate inflammation following spinal cord injury.

Authors:  Huiyuan Ji; Yuxin Zhang; Chen Chen; Hui Li; Bingqiang He; Ting Yang; Chunshuai Sun; Huifei Hao; Xingyuan Zhang; Yingjie Wang; Yue Zhou; Zhenjie Zhu; Yuming Hu; Aihong Li; Aisong Guo; Yongjun Wang
Journal:  J Neuroinflammation       Date:  2021-06-11       Impact factor: 8.322

7.  Macrophage Migration Inhibitory Factor in Acute Adipose Tissue Inflammation.

Authors:  Bong-Sung Kim; Robert Rongisch; Stephan Hager; Gerrit Grieb; Mahtab Nourbakhsh; Hans-Oliver Rennekampff; Richard Bucala; Juergen Bernhagen; Norbert Pallua
Journal:  PLoS One       Date:  2015-09-08       Impact factor: 3.240

8.  Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome.

Authors:  Milana Kokosar; Anna Benrick; Alexander Perfilyev; Romina Fornes; Emma Nilsson; Manuel Maliqueo; Carl Johan Behre; Antonina Sazonova; Claes Ohlsson; Charlotte Ling; Elisabet Stener-Victorin
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

9.  Altered Macrophage and Dendritic Cell Response in Mif-/- Mice Reveals a Role of Mif for Inflammatory-Th1 Response in Type 1 Diabetes.

Authors:  Yuriko Itzel Sánchez-Zamora; Imelda Juarez-Avelar; Alicia Vazquez-Mendoza; Marcia Hiriart; Miriam Rodriguez-Sosa
Journal:  J Diabetes Res       Date:  2016-09-06       Impact factor: 4.011

10.  The Association of Higher Plasma Macrophage Migration Inhibitory Factor Levels with Lower Bone Mineral Density and Higher Bone Turnover Rate in Postmenopausal Women.

Authors:  Hyeonmok Kim; Seong Hee Ahn; Chaeho Shin; Seung Hun Lee; Beom Jun Kim; Jung Min Koh
Journal:  Endocrinol Metab (Seoul)       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.